SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Centers for Disease Control and Prevention. HIV/AIDS Surveillance Rep. 1999;11: 16.
  • 2
    Centers for Disease Control and Prevention. AIDS among persons aged >50 years—United States, 1991–1996. Morb Mortal Wkly Rep. 1998;47: 217.
  • 3
    Skiest DJ & Keiser P. Human immunodeficiency virus infection in patients older than 50 years: a survey of primary care physicians' beliefs, practices, and knowledge. Arch Fam Med. 1997;6: 28994.
  • 4
    Siegel K, Schrimshaw EW, Dean L. Symptom interpretation: implications for delay in HIV testing and care among HIV-infected late middle-aged and older adults. AIDS Care. 1999;11: 52535.DOI: 10.1080/09540129947686
  • 5
    El-Sadr W & Gettler J. Unrecognized human immunodeficiency virus infection in the elderly. Arch Intern Med. 1995;155: 1846.
  • 6
    Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. MMWR Morb Mortal Wkly Rep. 1999;48: 122.
  • 7
    Keitz SA, Bastian LA, Bennett CL, Oddone EZ, DeHovitz JA, Weinstein RA. AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med. 1996;11: 5916.
  • 8
    Arozullah AM, Yarnold PR, Weinstein RA, et al. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med. 2000;161: 10816.
  • 9
    Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis. 1999;28: 7405.
  • 10
    Bennett CL, Weinstein RA, Shapiro MF, et al. A rapid pre-admission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Resp Crit Care Med. 1994;150: 15037.
  • 11
    Bennett CL, Matthews WC, Kosecoft J, et al. Results of a consensus panel on process of care for patients with Pneumocystis carinii pneumonia. In: International Conference on AIDS. 1989;5: 204Abstract number M.B.P.:376.
  • 12
    The National Institutes of Health–University of California Expert Panel for Corticosteroid as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323: 15004.
  • 13
    American Hospital Association Guide to the Health Care Field. Chicago, Ill: American Hospital Association; 1996/1997.
  • 14
    Bennett CL, Garfinkle JB, Greenfield S, et al. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA. 1989;261: 29759.
  • 15
    Bennett CL, Schwartz DN, Parada JP, et al. Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest. 2000;117: 1106.
  • 16
    Effros RB, Allsopp R, Chiu C-P, et al. Shortened telomeres in the expanded CD29-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996;10: F1722.
  • 17
    Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1993;52: 6617.
  • 18
    Effros RB, Boucher N, Porter V, et al. Decline in CD28+ T Cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994;29: 6019.
  • 19
    Curtis JR, Bennett CL, Horner RD, et al. Variations in intensive care unit utilization for patients with human immunodeficiency virus–related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med. 1998;26: 66875.
  • 20
    Curtis JR, Yarnold PY, Schwartz DN, et al. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus–related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2000;162: 3938.
  • 21
    Justice AC & Whalen C. Aging in AIDS; AIDS and aging. J Gen Intern Med. 1996;11: 6457.
  • 22
    Bennett CB, Sipler AM, Parada JP, et al. Variations in Institutional Review Board Decisions for HIV Quality of Care Studies: a potential source of study bias. J Acquir Immune Defic Syndr. 2001; 26: 3901.
  • 23
    Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339: 1897904.